Related by context. All words. (Click for frequent words.) 84 Improves Outcomes 84 Improves Survival 83 Improve Survival 83 Phase 2b Clinical Trial 82 Advanced Prostate Cancer 82 Antitumor Activity 82 Newly Diagnosed Multiple Myeloma 82 Rheumatoid Arthritis Patients 82 Prolongs Survival 82 HER2 Positive Breast Cancer 82 Slow Progression 82 Meets Primary Endpoint 82 Improved Survival 82 Previously Treated 81 Renal Cell Carcinoma 81 Survival Benefit 81 Prostate Cancer Patients 81 Combination Treatment 81 Patients Treated With 81 Breast Cancer Recurrence 81 Adjuvant Treatment 81 Hormone Refractory Prostate Cancer 81 Appears Safe 81 Metastatic Colorectal Cancer 81 Patients Receiving 81 Drug Shows Promise 81 Chronic Hepatitis C 81 Resistant Hypertension 80 Soft Tissue Sarcoma 80 Metastatic Prostate Cancer 80 Treatment Reduces 80 Relapsed Refractory 80 Myelodysplastic Syndromes 80 Shows Promising 80 Is Well Tolerated 80 Investigational Treatment 80 Inhaled Corticosteroids 80 Adjuvant Chemotherapy 80 Pooled Analysis 80 Complicated Skin 80 Drug Candidate 80 Advanced Colorectal Cancer 80 Node Positive 80 Phase 2b Trial 80 Treatment Naive Patients 80 Proves Effective 80 Phase IIb Trial 80 Shows Efficacy 80 Enlarged Prostate 80 Patient Enrollment 80 Patients Treated 79 Drug Combo 79 Colorectal Cancer Patients 79 Prostate Cancer Vaccine 79 Ovarian Cancer Patients 79 FDA Approves Drug 79 Shows Promise Against 79 Knee Osteoarthritis 79 Clinical Trial Results 79 Severe Sepsis 79 Breast Cancer Treatment 79 Lung Cancer Patients 79 Chronic Hepatitis B 79 HCV Protease Inhibitor 79 Relapsed Multiple Myeloma 79 Patients Undergoing 79 Anti Tumor 79 Elderly Patients 79 Gene Variant 79 Long Term Efficacy 79 Study Evaluating 79 FDA Okays 79 Cholesterol Lowering Drug 79 Epilepsy Drug 79 Treatment Shows Promise 79 Combo Therapy 78 Statistically Significant 78 Clinical Trial Evaluating 78 Myeloma Patients 78 Adjunctive Therapy 78 Treating Chronic 78 Investigational Agent 78 Well Tolerated 78 Lowers Risk 78 Demonstrates Efficacy 78 Initiates Clinical Trial 78 Stomach Cancer 78 Boosts Survival 78 Multiple Myeloma Patients 78 Combination REOLYSIN R 78 Fungal Infections 78 Genes Predict 78 Subgroup Analysis 78 Blood Pressure Drug 78 Phase III Clinical Trial 78 Malignant Melanoma 78 Successfully Treated 78 Investigational Compound 78 Reduced Risk 78 Cutaneous T 78 Gout Drug 78 Heart Failure Patients 78 Phase III Trials 78 Study Shows Promise 78 Lupus Drug 78 Hepatocellular Carcinoma 78 Bladder Cancer 78 Reduces Mortality 78 Chronic Sinusitis 78 Receives Orphan Drug Designation 78 Gene Linked 78 Study Showed 78 Experimental Vaccine 78 Lung Cancer Trial 78 Patients Suffering 78 Metastatic Melanoma 78 Completes Patient Enrollment 78 Castration Resistant Prostate Cancer 78 Postmenopausal Osteoporosis 78 Trial Evaluating 78 Refractory Hodgkin Lymphoma 78 Brain Metastases 77 Previously Untreated 77 Lupus Nephritis 77 Phase III Trial 77 Lung Cancer Drug 77 Anti Tumor Activity 77 HER2 Positive 77 Adjuvant Therapy 77 Significantly Improved 77 Vaccine Adjuvant 77 Arthritis Drug 77 Phase 2b Study 77 Mouse Model 77 Initiate Clinical Trial 77 Significantly Reduced 77 Osteoporosis Drugs 77 Advanced Renal Cell 77 Gastric Cancer 77 Hormone Receptor Positive 77 Drug Prevents 77 Fewer Side Effects 77 Neoadjuvant Chemotherapy 77 Endometrial Cancer 77 Osteoporosis Drug 77 Bone Metastases 77 Drug Resistant 77 Obesity Linked 77 Advanced Ovarian Cancer 77 Treated Patients 77 Cancer Treatments 77 Schizophrenia Drug 77 Demonstrates Significant 77 Single Dose 77 Less Invasive 77 Potentially Fatal 77 Guidelines Issued 77 Infected Patients 77 Rotavirus Vaccine 77 Breast Cancer Patients 77 Slows Progression 77 Investigational Drug 77 Drug Fails 77 Demonstrated Significant 77 NDA Submission 77 Relapsing Multiple Sclerosis 77 Recurrent Breast Cancer 77 Novel Oral 77 FDA Approvals 77 Chemoradiation 77 Localized Prostate Cancer 77 Overactive Bladder 77 Submits NDA 77 Demonstrates Positive 77 Peginterferon 77 Treatment Experienced 77 Fast Track Status 77 Oral Fingolimod 77 Pediatric Patients 77 Phase IIb Clinical Trial 77 Increased Mortality 77 Chronic Myeloid Leukemia 77 Plus Ribavirin 77 Novel Treatments 77 Cognitive Impairment 77 Unfractionated Heparin 77 Proven Effective 77 Randomized Trials 77 Dose Escalation 77 Files IND 77 Serious Infections 77 Genes Linked 76 Relapsing Remitting Multiple Sclerosis 76 Demonstrates Potent 76 Androgen Deprivation Therapy 76 Advanced Pancreatic Cancer 76 FDA Accepts 76 Pivotal Phase 76 Oral Calcitonin 76 Prophylactic Treatment 76 Completes Enrollment 76 Present Preclinical Data 76 Improve Outcomes 76 Phase 2a Trial 76 Aggressive Prostate Cancer 76 Premenopausal Women 76 Data Suggest 76 Ischemic Stroke 76 Invasive Breast Cancer 76 Bone Fractures 76 Tyrosine Kinase Inhibitor 76 Disease Progression 76 Combination Therapy 76 Protease Inhibitor 76 Obese Patients 76 Protein Linked 76 Test Detects 76 Gene Mutation 76 Postmenopausal Women 76 Initiate Phase III 76 Kidney Transplant Patients 76 Vaccine Shows Promise 76 Stem Cell Treatment 76 Lung Cancer Survival 76 Cocaine Addiction 76 Cholesterol Drugs 76 Autoimmune Disease 76 Critically Ill Patients 76 Effectively Treats 76 First Patient Enrolled 76 See CLINICAL PHARMACOLOGY 76 Virus Linked 76 Carboplatin Paclitaxel 76 Blood Clots 76 Venous Thromboembolism 76 Benign Prostatic Hyperplasia 76 Preclinical Data 76 Vaccine Candidate 76 Naive Patients 76 Predict Risk 76 FDA Clears 76 Artery Disease 76 Commonly Used 76 Disease Modifying 76 Versus Placebo 76 Expanded Indication 76 Monotherapy 76 Shingles Vaccine 76 Topical Treatment 76 Efficacy Trial 76 Cholesterol Drug 76 Muscle Wasting 76 Confirmatory Phase 76 Statin Therapy 75 Partial Onset Seizures 75 Migraine Headaches 75 Gum Disease 75 Advanced Solid Tumors 75 Prolongs Life 75 Metastatic Renal Cell Carcinoma 75 Transplant Patients 75 Teva Provides Update 75 Diabetic Patients 75 Fracture Risk 75 Pivotal Study 75 Effective Than 75 Sustained Efficacy 75 Hypertensive Patients 75 Nicotine Vaccine 75 Cardiovascular Events 75 Sleep Disturbances 75 Cell Transplants 75 Diabetic Foot Ulcer 75 Viral Infection 75 Granted Orphan Drug 75 Demonstrates Potential 75 Beta Blocker 75 Hormone Therapy 75 Prostate Cancer Treatment 75 Anal Cancer 75 Diabetic Neuropathy 75 Phase IIa Clinical Trial 75 Pharmacokinetic Study 75 Initiates Phase III 75 Fixed Dose 75 Diabetic Nephropathy 75 Lung Cancers 75 Pivotal Phase III 75 Clinical Outcome 75 Renal Cancer 75 Statin Drugs 75 Secondary Hyperparathyroidism 75 Drug Coated Stents 75 Unresectable 75 Transdermal Patch 75 Non Invasive Treatment 75 Reduces Pain 75 Blood Cancers 75 Tumor Growth 75 Beneficial Effects 75 Smallpox Vaccine 75 Novel Compounds 75 Radical Prostatectomy 75 Kidney Failure 75 Metastatic Pancreatic Cancer 75 Psoriasis Drug 75 Presents Preclinical Data 75 Pulmonary Arterial Hypertension 75 Long Term Survival 75 ORLive Presents 75 Reduces Risk 75 Immune Cells 75 Antiviral Drugs 75 Novel Antibiotic 75 Meta Analysis 75 Kidney Function 75 Rectal Cancer 75 Colorectal Adenomas 75 Treatment Naïve 75 Newly Diagnosed 75 Treat Anemia 75 Renal Function 75 Minimally Invasive Treatment 75 Osteoarthritis Patients 75 Study Demonstrates 75 IND Application 75 Stem Cell Transplants 75 Therapy Improves 75 Heartburn Drugs 75 TNF Blockers 75 Demonstrates Sustained 75 Malignant Glioma 75 Osteoporosis Treatment 75 Hepatitis C Genotype 75 Poorly Controlled 75 Contrast Agents 75 Atopic Dermatitis 75 Asthma Treatment 75 Hepatitis B Vaccine 75 Breast Tumors 75 Causes Symptoms 75 Vaccine Protects Against 75 Breast Cancers 75 Clostridium difficile Infection 75 Kidney Transplant Recipients 75 Premature Infants 75 Renal Impairment 75 Severe Asthma 75 ST Elevation Myocardial 75 Cancer Recurrence 75 Increases Risk 75 Genes Associated 74 Epilepsy Drugs 74 Pre Cancerous 74 Fondaparinux 74 Treat Heart Failure 74 Prevent Breast Cancer 74 Uterine Fibroids 74 Prospective Randomized 74 Successfully Treats 74 Anemia Drug 74 Hematological Malignancies 74 II Clinical Trial 74 Showed Significant 74 Virus Infection 74 Hepatitis C Patients 74 ACE Inhibitors 74 Successfully Completes Phase 74 Randomized Double Blind 74 Carotid Stenting 74 Clinical Trial Data 74 Blood Thinner 74 Newly Diagnosed Breast Cancer 74 Randomized Phase 74 Phase 2a Clinical Trial 74 Mylan Receives Approval 74 Develop Novel 74 Treatment Resistant 74 Rheumatoid Arthritis Drug 74 Blood Pressure Drugs 74 Pivotal Trials 74 Emerging Therapies 74 Pneumococcal Vaccine 74 Shows Promise 74 Hospital Acquired Pneumonia 74 Peginterferon Alfa 2a 74 Autologous Stem Cell Transplantation 74 Inhaled Insulin 74 Intracerebral Hemorrhage 74 Chemotherapy Improves 74 Prove Effective 74 Invasive Fungal Infections 74 Liver Failure 74 Pivotal Trial 74 Metabolic Disorder 74 Clot Busting 74 Anthracycline 74 Therapy Shows Promise 74 Treatable 74 Brain Atrophy 74 Viral Load 74 Chronic Lymphocytic Leukemia 74 Oral Mucositis 74 Follicular Lymphoma 74 Treatment Naive 74 Bone Marrow Cells 74 Genetic Tests 74 Preterm Delivery 74 Anticancer Activity 74 Erectile Dysfunction Drug 74 Begins Dosing 74 Anticancer Drug 74 Acute Exacerbations 74 Skin Lesions 74 Septic Shock 74 Seasonal Influenza Vaccine 74 Bipolar Mania 74 Randomized Phase II 74 NICE Recommends 74 Significant Reduction 74 Significantly Reduces 74 Phase 1b Clinical Trial 74 Initiate Phase 74 Immunomedics Announces 74 Acute Ischemic Stroke 74 Excessive Sweating 74 Cardiovascular Outcomes 74 Estrogen Therapy 74 Randomized Controlled Trials 74 Peginterferon Alfa 2b 74 Prostate Tumors 74 Skin Cancers 74 Inflammatory Disease 74 Initiates Enrollment 74 Obese Teens 74 Reduce Mortality 74 Achieves Primary Endpoint 74 Meet Primary Endpoint 74 Brentuximab Vedotin SGN 74 Treating Heart Failure 74 Spinal Fusion 74 JAK Inhibitor 74 Therapy Reduces 74 Breast Density 74 Often Misdiagnosed 74 Treatment Naive HIV 74 Lung Tumors 74 Gene Mutations 74 Chemotherapy Regimen 74 Allergic Rhinitis 74 Taxane 74 Ebola Vaccine 74 Inflammatory Markers 74 Treatment Regimen 74 Beta Blockers 74 Kidney Transplants 74 Migraine Treatment 74 Dose Finding 73 Antibody Drug Conjugate 73 Genital Herpes 73 Initiates Phase II 73 AVI BioPharma Announces 73 Initiates Clinical 73 Insulin Glargine 73 Solid Tumors 73 CDC Recommends 73 Psoriasis Patients 73 Acute Pancreatitis 73 Sinus Infections 73 Levels Linked 73 Receives Positive Opinion 73 Shown Effective 73 Presents Positive 73 Molecular Diagnostic Test 73 Liver Metastases 73 Atypical Hemolytic Uremic Syndrome 73 Weight Loss Drug 73 Hypercholesterolemia 73 Severe Acne 73 Relapsed Refractory Multiple Myeloma 73 Prevent Stroke 73 Cell Lymphoma 73 Newly Diagnosed Patients 73 ARIXTRA R 73 Cervical Cancer Vaccine 73 Male Contraceptive 73 Chronic Renal Failure 73 Blood Clot Risk 73 Hematological Cancers 73 Bloodstream Infections 73 Pivotal Clinical Trial 73 Oral Cladribine 73 Telaprevir VX 73 Sustained Reduction 73 Hepatitis C Treatment 73 Migraine Pain 73 Therapeutic Efficacy 73 Help Smokers Quit 73 Genetic Variant 73 Migraine Headache 73 Pneumonia Vaccine 73 Asthma Attacks 73 Panic Disorder 73 Efficacious 73 Genetic Predisposition 73 Antibiotic Treatment 73 Node Negative 73 SPRYCEL ® 73 Moderate Drinking 73 Antipsychotic Drug 73 Medoxomil 73 RNAi Therapeutic 73 Inhaled Nitric Oxide 73 Antibiotic Resistant 73 Vitrasert R 73 Menopausal Women 73 Randomized Clinical Trials 73 Bipolar Depression 73 Adenoma 73 Seasonal Allergic Rhinitis 73 Randomized Study 73 Antiangiogenic 73 Autoimmune Diseases 73 Vaccine Prevents 73 Interferon Beta 73 Predict Response 73 Receives Approvable Letter 73 JAK2 Inhibitor 73 Controlled Trial 73 Bone Marrow Transplants 73 Atypical Antipsychotics 73 Thromboembolism 73 Pegylated Interferon 73 Generic Versions 73 Acute Heart Failure 73 Demonstrate Significant 73 Diabetic Neuropathic Pain 73 Efficacy Results 73 Preclinical Models 73 Antipsychotic Medications 73 Myelofibrosis 73 Migraine Drug 73 Being Studied 73 Intravenous Formulation 73 Novel Compound 73 Hepatic Encephalopathy 73 Preclinical Study 73 Stable Coronary Artery 73 Randomized Clinical Trial 73 Significantly Improves 73 Cholesterol Lowering 73 Increased Risk 73 Symptom Relief 73 Acute Migraine 73 Lymphoma Patients 73 Prognostic Value 73 Antiviral Activity 73 Antidepressants Linked 73 Skeletal Muscle 73 Laryngeal Cancer 73 Renal Insufficiency 73 Predict Breast Cancer 73 Plaque Psoriasis 73 Arthritis Sufferers 73 Orally Active 73 Testosterone Patch 73 Blocked Arteries 73 Vaginal Gel 73 Bosutinib 73 Lowering Blood Pressure 73 Generic Version 73 Antifungal 73 Novel Vaccine 73 Colorectal Cancers 73 Oral Formulation 73 Ovary Removal 73 Minimally Invasive Procedure 73 Bone Fracture 73 Gene Therapy Trial 73 Blood Vessels 72 Antitumor 72 Malaria Vaccine 72 Genetic Mutation 72 Leukemias 72 Hemodialysis Patients 72 Renal Anemia 72 Genes Identified 72 Treating Depression 72 Gene Variation 72 Phase III Pivotal 72 Colon Polyps 72 Predict Prostate Cancer 72 Cardiovascular Disease Risk 72 Urine Test 72 Breast Tumor 72 ST Segment Elevation 72 Glufosfamide 72 Allergic Reactions 72 Vildagliptin 72 Receives Orphan Drug 72 Urinary Tract Infections 72 IND Filing 72 Lowers Blood Pressure 72 Cholesterol Levels 72 Sipuleucel T 72 STELARA TM 72 Vitamin D Linked 72 Strongly Linked 72 Hormone Replacement 72 Study Evaluates 72 Confirms Efficacy 72 Randomized Double blind 72 Calcium Supplements 72 Immune Responses 72 Study Casts Doubt 72 Targeted Therapy 72 Contrast Agent 72 Oral Cavity 72 Prognostic Significance 72 Chronic Heart Failure 72 Seasonal Allergies 72 FDA Panel Recommends 72 MEK Inhibitor 72 Tezampanel 72 Controlled Study 72 Dialysis Patients 72 Thyroid Cancer 72 Smoking Linked 72 Clinical Efficacy 72 Chronic Constipation 72 R lenalidomide 72 Prostate Surgery 72 Immunotherapeutic 72 Cognitive Function 72 Recurrent Ovarian Cancer 72 Treatment Naïve Patients 72 Gene Variants 72 Survival Rates 72 Gastric Ulcers 72 Therapeutic Vaccines 72 Valopicitabine 72 Begin Clinical Trials 72 MRSA Infections 72 Basal Cell 72 Spectrum Pharmaceuticals Announces 72 Schizophrenia Treatment 72 Guidelines Recommend 72 Anticoagulant 72 Prostate Biopsy 72 Colorectal Cancer Risk 72 Complete Remission 72 Prognostic Factors 72 Prostate Cancers 72 Anti Clotting Drug 72 Gene Mutation Linked 72 Low Dose 72 Commonly Prescribed 72 Study Compares 72 Acute Coronary Syndromes 72 Helps Smokers Quit 72 Chronic HCV 72 Periodontal Disease 72 Topline Results 72 Dose Ranging 72 Tiotropium 72 Shows Statistically Significant 72 Hip Fractures 72 Novel Mechanism 72 Post Menopausal 72 Breast Cancer Cells 72 Bucindolol Based 72 Epratuzumab 72 Progressive Multifocal Leukoencephalopathy 72 Anti Inflammatory Drug 72 Hemoglobin Levels 72 Idiopathic Pulmonary Fibrosis 72 Parathyroid Hormone 72 Organ Rejection 72 Acute Attacks 72 Higher Doses 72 Systemic Sclerosis 72 Lung Injury 72 Novel Therapeutic 72 Relapsed Refractory Aggressive 72 Skin Infections 72 Brain Tumor Patients 72 Chemotherapy Induced 72 Preterm Labor 72 Squamous Cell Carcinoma 72 Radiofrequency Ablation 72 Left Ventricular Hypertrophy 72 Long Term Outcomes 72 Brain Scans 72 Universal Flu Vaccine 72 Brain Aneurysms 72 Gastrointestinal Disorders 72 Post Operative 72 Ovarian Cancer Treatment 72 Bivalirudin 72 Androgen Independent 72 Early Diagnosis 72 Primary Hypercholesterolemia 72 Neoadjuvant 72 FDA Clearance 72 Viral Infections 72 Desvenlafaxine Succinate 72 Pulmonary Artery 72 Paraplatin ® 72 Anti Angiogenesis 72 Therapeutic Potential 72 Zoledronic Acid 72 Pregnancy Linked 72 Accurate Diagnosis 72 Valvular Heart Disease 72 Hsp# Inhibitor 72 Aspirin Reduces 72 Clinically Tested 72 Mg Uk 72 Clinically Significant 72 Immune Cell 72 Heart Stents 72 Cognitive Decline 72 Mayo Clinic Study Finds 72 Glatiramer Acetate 72 Inhaled Steroids 72 Effective Treatments 72 Cardiac Resynchronization 72 Kidney Stones 72 Cancer Diagnosis 72 Acne Drug 72 Bacterial Infections 72 Thromboembolic 72 Dose Ranging Study 72 Benign Prostatic Hyperplasia BPH 72 Chemotherapeutic Agents 72 Lung Cancer Treatment 72 Demonstrates Statistically Significant 72 Diagnostic Tests 71 First Patient Treated 71 Lower Blood Pressure 71 Mouse Models 71 Antidepressant Use 71 Abdominal Pain 71 Uterine Cancer 71 Varicose Veins 71 Initiates Dosing 71 Limb Ischemia 71 Ovarian Cancers 71 Uterine Fibroid Embolization 71 Non Inferiority 71 Kinase Inhibitor 71 Chronic Cough 71 Tolerability 71 Liver Injury 71 Platinol ® 71 Antipsychotic Drugs 71 Arterial Disease 71 Venous Thrombosis 71 Protein Involved 71 Study Shows Benefits 71 Urinary Incontinence 71 Sangamo BioSciences Announces 71 Double Blind Placebo 71 Active Rheumatoid Arthritis 71 Postherpetic Neuralgia 71 Helps Predict 71 Combination Vaccine 71 Nymox NX 71 Renal Cell Cancer 71 Elotuzumab 71 Metastatic Breast Cancer 71 Drug Resistant TB 71 Antibiotic Use 71 Chronic Bronchitis 71 Coronary Arteries 71 Help Predict 71 Antiviral Therapy 71 Immunosuppressant 71 Helps Relieve 71 FDA APPROVES 71 Circulating Tumor Cells 71 Diabetic Macular Edema 71 Liver Tumors 71 Milestone Payment 71 Squamous 71 Potentially Deadly 71 Physician Insights 71 Antiplatelet 71 Potent Anti 71 Patient Outcomes 71 Anemia Drugs 71 Unstable Angina 71 Initiates Phase 2b 71 Lymphocytic 71 IIa Clinical Trial 71 Knee Arthritis 71 Ventricular Arrhythmias 71 Cervical Dysplasia 71 Bazedoxifene 71 Significant Improvement 71 Childhood Leukemia 71 Aflibercept 71 Short Stature 71 Eases Pain 71 Double Blind Randomized 71 Therapeutic Vaccine 71 Gets FDA Clearance 71 Commercialize Novel 71 Cognitive Deficits 71 Mimetics 71 Allogeneic 71 Lung Transplants 71 Hyperlipidemia 71 First Patient Dosed 71 Submits Supplemental 71 Myelodysplastic Syndrome 71 Platelet Inhibition 71 Diabetic Kidney Disease 71 Anti Inflammatory 71 Oral Anticoagulant 71 Neuroendocrine Tumors 71 Vicriviroc 71 Supplemental Biologics License Application 71 Muscle Function 71 Autoimmune Disorders 71 Drug Coated Stent 71 Recombinant Human 71 Synthetic Peptide 71 Colorectal Screening 71 Watchful Waiting 71 Calcium Vitamin D 71 Juvenile Idiopathic Arthritis 71 Respiratory Distress 71 Brain Tumors 71 Generalized Anxiety Disorder 71 Novel Inhibitor 71 Hematopoietic Stem Cell Transplantation 71 Osteoarthritis Pain 71 Irregular Heartbeat 71 Myelodysplastic Syndrome MDS 71 Balloon Angioplasty 71 Dupuytren Contracture 71 Improve Diagnosis 71 Thrombotic 71 Collaborators Present 71 Oral Laquinimod 71 Non Melanoma Skin 71 Genetic Mutations 71 Chronic Pelvic Pain 71 Epileptic Seizures 71 PRN FDA Approves 71 Targeted Therapies 71 Systemic Delivery 71 B Cell Malignancies 71 Chronic Kidney 71 Severely Obese 71 Anti Nausea 71 HCV Genotype 71 Interferon beta 1a 71 Polymerase Inhibitor 71 Surgical Procedures 71 Insulin Resistance 71 RNAi Therapeutics 71 Chronic Liver Disease 71 HDAC Inhibitor 71 Peptic Ulcer 71 Esophageal Cancer 71 Orthostatic Hypotension 71 Earns Milestone Payment 71 Heart Transplant Recipients 71 Diamyd Medical Diamyd 71 Hepatitis C Virus 71 Presents Preclinical 71 Mg Usa 71 Protease Inhibitors 71 Subtypes 71 Prevent Heart 71 Treating Prostate Cancer 71 Initiates Clinical Trials 71 Patient Treated 71 R Bortezomib 71 Alternative Treatments 71 Receives Fast Track 71 achieved CCyR 71 Antiplatelet Therapy 71 Holds Promise 71 Capecitabine 71 Non Responders 71 Renal Artery 71 Fibromyalgia Pain 71 Submits Biologics License Application 71 Files Investigational 71 Mesothelioma Treatment 71 Rotavirus Vaccines 71 Viral Suppression 71 Dose Response 71 Prevent Prostate Cancer 71 Phospholipase A2 71 Prostate Cancer Progression 71 Tyrosine Kinase Inhibitors 71 Genetic Markers 71 FASLODEX 71 Drug Combinations 71 Cancer Cells 71 Could Prevent 71 Epoetin Alfa 71 Seasonal Flu Vaccine 71 Statin Use 71 Bare Metal Stents 71 Dual Antiplatelet Therapy 71 Placebo Controlled Study 71 #-# Full Text 71 Tuberculosis Vaccine 71 Monoclonal Antibody 71 Generic Version Of 70 Physical Function 70 Iron Overload 70 Refractory Angina 70 Lung Function 70 Severe Psoriasis 70 Growth Hormone Deficiency 70 Paclitaxel Carboplatin 70 Bacterial Infection 70 Orphan Status 70 Detect Cancer 70 Inflammatory Arthritis 70 Clinical Evaluation 70 Heterozygous Familial Hypercholesterolemia 70 Asthma Symptoms 70 Precancerous 70 Reports Preclinical Data 70 Lung Cancer Risk 70 Crit Rev 70 Diagnostic Criteria 70 Silicone Breast Implants 70 Human Monoclonal Antibody 70 Fluorouracil 70 Syncria R 70 Recurrent Prostate Cancer 70 Clinical Outcomes 70 Ear Infections 70 Eculizumab 70 TB Vaccine 70 Epidermal Growth Factor Receptor 70 Diffuse Large B 70 Genital Warts 70 Immunosuppression 70 Catheter Ablation 70 Neovascular Age Related Macular 70 Placebo Controlled Trial 70 Transplant Rejection 70 Non Alcoholic Fatty 70 Maven Semantic 70 Nasal Powder 70 Improve Patient Outcomes 70 Live Attenuated 70 Regimens 70 Therapeutic Antibody 70 Fat Cells 70 Opioid Addiction 70 Migraine Sufferers 70 Atypical Antipsychotic 70 Cardiogenic Shock 70 Pegylated Liposomal Doxorubicin 70 Romiplostim 70 Glycemic Control 70 Phase Ib Clinical Trial 70 HPV Infection 70 Menstrual Cramps 70 Pancreatic Adenocarcinoma 70 Interferon Alpha 70 Genetic Disorder 70 Dengue Virus 70 Tumor Cells 70 Hepatocellular 70 Electrical Stimulation 70 Therapy Evaluation 70 Bevacizumab 70 Seasonal Influenza 70 FDA Warns Against 70 Multicenter Trial 70 Healthbeat Report 70 Cancer Vaccines 70 FDA Approves Novel 70 Doctors Warn 70 Visceral Fat 70 Crofelemer budesonide foam 70 Lymph Nodes 70 Lymph Node 70 Androgen Deprivation 70 Arthritis Drugs 70 Receives Milestone Payment 70 Chronic Insomnia 70 Stereotactic Body Radiation Therapy 70 Dementia Risk 70 Announces FDA Clearance 70 Percutaneous Tibial Nerve Stimulation 70 Antipsychotic 70 Diet Linked